Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Olink Holding Ab [Publ] ADR (OLK)

Olink Holding Ab [Publ] ADR (OLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,242,866
  • Shares Outstanding, K 124,343
  • Annual Sales, $ 169,600 K
  • Annual Income, $ -31,600 K
  • EBIT $ -58 M
  • EBITDA $ -39 M
  • 60-Month Beta 0.52
  • Price/Sales 19.06
  • Price/Cash Flow N/A
  • Price/Book 7.02
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.27
  • Most Recent Earnings $-0.13 on 05/13/24
  • Next Earnings Date 08/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.11
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.13
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.51 +6.41%
on 06/12/24
26.09 -0.04%
on 07/09/24
+1.43 (+5.80%)
since 06/07/24
3-Month
21.80 +19.63%
on 04/19/24
26.09 -0.04%
on 07/09/24
+2.93 (+12.66%)
since 04/09/24
52-Week
14.10 +84.96%
on 10/03/23
26.09 -0.04%
on 07/09/24
+8.02 (+44.41%)
since 07/07/23

Most Recent Stories

More News
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment

At this juncture, the promising proteomics market is too small to be a surefire investment.

QSI : 1.7200 (-4.97%)
TMO : 522.74 (-0.36%)
OLK : 26.08 (+0.31%)
Should You Still Buy the Nasdaq's Best-Performing October Stocks?

Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them.

COMP : 6.89 (-0.14%)
GPCR : 31.45 (-0.82%)
IBRX : 2.87 (-5.59%)
OLK : 26.08 (+0.31%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VSTO, OLK, PNT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VSTO : 44.63 (+0.54%)
OLK : 26.08 (+0.31%)
PNT : 12.50 (+0.16%)
Why Olink Stock Is Skyrocketing Today

Investors are cheering a huge acquisition offer from Thermo Fisher.

OLK : 26.08 (+0.31%)
TMO : 522.74 (-0.36%)
DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS

/PRNewswire/ -- Discovery Life Sciences™ (Discovery) today announced the launch of its new Proteomic Services Division and is now accepting samples from...

SEER : 2.44 (-0.81%)
OLK : 26.08 (+0.31%)
Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer

Personalis, Inc. (Nasdaq: PSNL) has joined with Duke University and Olink Proteomics AB to form a research collaboration to study the effects of immunotherapy on advanced gastroesophageal cancer. Specifically,...

PSNL : 3.50 (-2.23%)
OLK : 26.08 (+0.31%)
DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE

/PRNewswire/ -- Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ)...

OLK : 26.08 (+0.31%)
Olink to report second quarter 2022 financial results on August 11, 2022

UPPSALA, Sweden, July 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for...

OLK : 26.08 (+0.31%)
Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insight

UPPSALA, Sweden, June 28, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the release of Olink® Analyze 3.1. Olink®...

OLK : 26.08 (+0.31%)
UK Biobank Pharma Proteomics Project publishes early results from its pioneering proteomics research

UPPSALA, Sweden, June 21, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) announced that a publication describing the early findings of...

OLK : 26.08 (+0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Olink Holding AB provides a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic institutions to deepen the understanding of real-time human biology. It operates principally in Europe, North America and Asia. Olink Holding AB is headquartered...

See More

Key Turning Points

3rd Resistance Point 26.23
2nd Resistance Point 26.16
1st Resistance Point 26.12
Last Price 26.08
1st Support Level 26.01
2nd Support Level 25.94
3rd Support Level 25.90

See More

52-Week High 26.09
Last Price 26.08
Fibonacci 61.8% 21.51
Fibonacci 50% 20.10
Fibonacci 38.2% 18.68
52-Week Low 14.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar